Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Part of paid clinical trials in Gainesville, Florida.

Sponsor
University of Florida
Study ID
NCT07009717
Status
Recruiting
Apply to this trial

Conditions

  • Chemotherapy-induced Peripheral Neuropathy (CIPN)
  • Healthy

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Accepted

Interventions

  • No intervention (observational study) — OTHER
    No intervention; observational study

Study Details

Great Toe Strength (GTS) is a potential clinical biomarker that has been associated with functional mobility and health; Additionally, GTS has been identified in the literature as one of the early symptoms of chemotherapy-induced peripheral neuropathy (CIPN). The purpose of this research study is to evaluate GTS in individuals with CIPN and healthy adults using ToeScale and see how it relates to nerve issues from chemotherapy. Additionally, we aim to assess the usability of the novel GTS assessment device, ToeScale among the participants. As a part of this study visit, you will complete some questionnaires followed by GTS and balance and gait assessments.

Key Dates

Start date
Aug 5, 2025
Status verified
Aug 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: CIPN
    Individuals with chemotherapy-induced peripheral neuropathy with a confirmed diagnosis using the nerve conduction study
  • Arm: Healthy
    Healthy adults with no known health conditions affecting their mobility, balance, or lower extremity muscle strength

Primary Outcome Measure

Great Toe Strength [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of FloridaGainesvilleFlorida32611
Hongwu Wang, PhD
[email protected]
352-273-9934
Hongwu Wang, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Gainesville, FL

By research site
University of Florida· Gainesville, FL

Related Studies